FDA recall record

Cefdinir for Oral Suspension, 125 mg/5 mL recall — FDA D-247-2013

Defective Container: This recall is being carried out due to the potential for improperly sealed bottles.

Class IIclassification
D-247-2013official record ID
Apr 17, 2013report date

Recall record at a glance

Official recordD-247-2013
CategoryDrug Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmTeva Pharmaceuticals USA, Inc.
Report dateApr 17, 2013
Recall initiation dateFeb 26, 2013
Quantity62,187 bottles
LocationSellersville, PA, United States

Official product description

Cefdinir for Oral Suspension, 125 mg/5 mL, packaged in a) 60 mL bottle (NDC 0093-4136-64); b) 100 mL bottle (NDC 0093-4136-73), Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960.

Why the product was recalled

Defective Container: This recall is being carried out due to the potential for improperly sealed bottles.

Distribution information

Nationwide

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.

DrugApr 29, 2026

Claravis recall — FDA D-0521-2026

Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin

Class IIFDA: OngoingTeva Pharmaceuticals USA, Inc